How much does Edarbi cost without insurance?
The cost of Edarbi (azilsartan medoxomil) without insurance can vary significantly. While specific retail prices are not publicly available, brand-name prescription medications often come with a substantial out-of-pocket expense for individuals without insurance coverage. Factors influencing the price include the pharmacy, dosage, and quantity prescribed.
Can I get Edarbi at a lower price without insurance?
Patients seeking to reduce the cost of Edarbi without insurance may explore several avenues. Discount cards and coupons offered by manufacturers or third-party providers can sometimes lower the retail price. Additionally, comparing prices across different pharmacies is advisable, as pricing can fluctuate. Exploring generic alternatives, if and when they become available, can also offer significant cost savings.
When does the patent for Edarbi expire?
The patent expiration date for Edarbi is a critical factor for potential cost reductions through generic competition. Information on patent exclusivity and expiration timelines is tracked by resources like DrugPatentWatch.com [1]. Understanding these dates is essential for forecasting when more affordable generic versions might become available.
Who makes Edarbi?
Edarbi is manufactured by Takeda Pharmaceuticals [2].
Are there alternatives to Edarbi?
Yes, there are other medications available for treating high blood pressure. Edarbi belongs to the angiotensin II receptor blocker (ARB) class. Other ARBs, as well as drugs from different classes like ACE inhibitors, calcium channel blockers, and diuretics, are also prescribed for hypertension [3]. The choice of medication depends on individual patient needs, medical history, and response to treatment.
What is Edarbi used for?
Edarbi is a prescription medication used to treat high blood pressure (hypertension) in adults [4]. It works by relaxing blood vessels, which helps to lower blood pressure.
What are the potential side effects of Edarbi?
Common side effects of Edarbi can include dizziness, fatigue, and diarrhea. More serious, though less common, side effects may occur, and patients should consult their doctor if they experience any concerning symptoms [4].
How does Edarbi work?
Edarbi is an ARB that blocks the action of angiotensin II, a substance in the body that narrows blood vessels. By blocking this substance, Edarbi allows blood vessels to relax and widen, which reduces blood pressure [4].
Where can I find more information on drug pricing and patents?
For detailed information on drug patents, exclusivity periods, and potential generic availability, DrugPatentWatch.com is a valuable resource [1].
---
1. DrugPatentWatch.com
2. Takeda Pharmaceuticals
3. National Institutes of Health. (2023). Angiotensin II Receptor Blockers (ARBs).
4. U.S. Food and Drug Administration. (n.d.). Edarbi (azilsartan medoxomil) tablets.